Mismatched transplants for refractory lymphoma?
- 1 May 1999
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 353 (9166) , 1725-1726
- https://doi.org/10.1016/s0140-6736(98)00402-4
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- T cells recognizing leukemic CD34 + progenitor cells mediate the antileukemic effect of donor lymphocyte infusions for relapsed chronic myeloid leukemia after allogeneic stem cell transplantationProceedings of the National Academy of Sciences, 1998
- Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies.Journal of Clinical Oncology, 1998
- Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic DiseasesBlood, 1998
- Human minor histocompatibility antigens: new concepts for marrow transplantation and adoptive immunotherapyImmunological Reviews, 1997
- Cytotoxic T-lymphocyte (CTL) responses against acute or chronic myeloid leukemiaImmunological Reviews, 1997
- Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.Journal of Clinical Oncology, 1997
- Megadose of T cell-depleted bone marrow overcomes MHC barriers in sublethally irradiated miceNature Medicine, 1995